CAPTRUST Financial Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $237K | Buy |
|
|||||
|
2024
Q4 | $282K | Buy |
|
|||||
|
2024
Q3 | $413K | Sell |
|
|||||
|
2024
Q2 | $373K | Buy |
|
|||||
|
2024
Q1 | $321K | Sell |
|
|||||
|
2023
Q4 | $509K | Sell |
|
|||||
|
2023
Q3 | $430K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $96K | Buy |
|
|||||
|
2022
Q1 | $128K | Buy |
|
|||||
|
2021
Q4 | $69K | Sell |
|
|||||
|
2021
Q3 | $83K | Buy |
|
|||||
|
2021
Q2 | $77K | Sell |
|
|||||
|
2021
Q1 | $82K | Buy |
|
|||||
|
2020
Q4 | $3K | Sell |
|
|||||
|
2020
Q3 | $8K | Buy |
|
|||||
|
2020
Q2 | $6K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $15K | Buy |
|